Seller record · Telehealth service

Zealthy

By Peptide Alliance, Editorial publisherRecorded September 2026 · Standard v1.1 · How checks are performed

Fails 3 of 8 criteria. S3, pharmacy identification: Every reference to the filler reads partner pharmacy, and no facility is named. The questions, terms, telehealth consent, refunds, contact and privacy surfaces carry it. 2 more criteria also fail; see the table below.

At a glance

ZealthyTelehealth service

5/8criteria passed

Price: Semaglutide $217 first month, then $297
Sells: compounded semaglutide, compounded tirzepatide, and 4 more
FDA letters: 1 on file

Visit Zealthy See all eight dispositions

Telehealth service. Passes 5 of 8 criteria. Recorded against Standard v1.1.

A telehealth service selling compounded semaglutide and tirzepatide beside brand GLP-1 prescriptions and several unrelated treatment lines. Its own pages name Zealthy, Inc. as the operator while the FDA letter addressed to this storefront names FitRX, LLC, and the two names are reconciled nowhere on the site.

Operating entity Zealthy, Inc.

Dispositions

Code	Criterion	Disposition	Where it appears
S1	Prescriber requirement	PASS	Zealthy's weight loss FAQ
S2	Prescription gating	PASS	Zealthy's get started page on its health storefront
S3	Pharmacy identification	FAIL	Zealthy's terms of use page
S4	Compounding disclosure	FAIL	Zealthy's weight loss FAQ
S5	Analytical documentation	FAIL	Zealthy's FAQ
S6	Business address	PASS	Zealthy's privacy policy
S7	Price disclosure	PASS	Zealthy's weight loss FAQ
S8	Enforcement status	PASS	FDA warning-letter index

Evidence, criterion by criterion

The evidence behind each disposition in the table above, where it appears, and its date.

S1PASSThe weight-loss questions page states that providers are United States licensed, board certified physicians and nurse practitioners, and it names no individual prescriber.Source: Zealthy's weight loss FAQ.

S2PASSA health question about treatment goals comes first, then an account screen, before any product page or payment field.Source: Zealthy's get started page on its health storefront.

S3FAILEvery reference to the filler reads partner pharmacy, and no facility is named. The questions, terms, telehealth consent, refunds, contact and privacy surfaces carry it.Source: Zealthy's terms of use page.

S4FAILThe word compounded appears throughout the weight-loss questions page, and no page states that a compounded product lacks Food and Drug Administration approval.Source: Zealthy's weight loss FAQ.

S5FAILNo certificate, lot number or purity figure appears on the site.Source: Zealthy's FAQ.

S6PASSThe privacy policy prints a street address with a floor at 30 Irving Place in New York, and the weight-loss page footer repeats it with a telephone number.Source: Zealthy's privacy policy.

S7PASSThe weight-loss questions page prints a semaglutide bundle at 217 dollars for the first month and 297 dollars per month after, and a tirzepatide bundle at 349 dollars then 449 dollars.Source: Zealthy's weight loss FAQ.

S8PASSFDA warning letter 716501, September 2025, names FitRX, LLC doing business as Zealthy at the street address this site prints, and cites claims of the same active ingredient as an approved drug. No FDA action has halted the business, and the seller still trades.Source: FDA warning-letter index.

Products shown on the seller's own pages at the recorded date: compounded semaglutide, compounded tirzepatide, brand GLP-1 prescriptions, birth control, hair loss and erectile dysfunction medications, mental health prescriptions.

Other sellers of the same products

Who sells semaglutide Who sells tirzepatide

Enforcement documents on file: 1 warning letter

FDA warning letter 716501, issued September 2025, to FitRX, LLC dba ZealthyClaims on Zealthy's website that compounded semaglutide is the same active ingredient as Wegovy and Ozempic are false or misleading.

A warning letter alleges violations and requests a response. It does not halt a business, and it does not remove a seller from this ledger. Every letter recorded here.

Visit Zealthy

Dispositions recorded against Standard v1.1. Method and null semantics: how checks are performed. This record is not a review and contains no medical advice.